Ocular Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Ocular Cancer Drug Development Pipeline Review, 2018

  • Report
  • 63 Pages
From
Myelodysplastic Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2018

  • Report
  • 1006 Pages
From
Cancer Metabolism Based Therapeutics, 2017-2030 - Product Thumbnail Image

Cancer Metabolism Based Therapeutics, 2017-2030

  • Report
  • 263 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Report
  • 2011 Pages
From
Uveal Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H1 2018

  • Report
  • 185 Pages
From
Uveal Melanoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H2 2017

  • Report
  • 155 Pages
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • Report
  • 2103 Pages
From
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • Report
  • 1458 Pages
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2018 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2018

  • Report
  • 925 Pages
From
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018 - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018

  • Report
  • 965 Pages
From
Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016 - Product Thumbnail Image

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

  • Report
  • 477 Pages
From
Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016 - Product Thumbnail Image

Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

  • Report
  • 442 Pages
From
Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016 - Product Thumbnail Image

Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

  • Report
  • 489 Pages
From
Colon Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2018

  • Report
  • 782 Pages
From
Prostate Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H1 2018

  • Report
  • 2069 Pages
From
Breast Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Breast Cancer - Pipeline Review, H2 2016

  • Report
  • 3149 Pages
From
Small-Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Small-Cell Lung Cancer - Pipeline Review, H1 2018

  • Report
  • 810 Pages
From
Breast Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Breast Cancer - Pipeline Review, H1 2016

  • Report
  • 3011 Pages
From
Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Aeglea BioTherapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Aeglea BioTherapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Loading Indicator
adroll